Bottom Line Newer prescription weight loss drugs like Wegovy, Foundayo or Zepbound can produce dramatic weight loss results of 10 to 20% or more, but come with an initial risk of stomach-related side effects, like nausea, vomiting, diarrhea, constipation or stomach-area pain
Discontinuation rates due to adverse events ranged from 0-6% depending on the dose group, which is comparable to or lower than rates seen with semaglutide (7% in STEP 1) and tirzepatide (4-7% in SURMOUNT-1)
Demand has outpaced quality across the market, and independent testing regularly exposes underdosed or impure vials from unverified suppliers
However, translating findings from rodent models to humans requires caution
Direct Meds operates as the coordination platform: it handles the intake process, the telehealth consultation, and the logistics